Print Magazine
Brussels Morning Newspaper
Wednesday, June 29, 2022
No Result
View All Result
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Newspaper
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Newspaper
No Result
View All Result
Home EU Institutions

EU addresses chronic medicine shortages

Marta Pacheco by Marta Pacheco
29 October 2021
in EU Institutions
EU addresses chronic medicine shortages
Share on FacebookShare on Twitter

Brussels (Brussels Morning) The European Medicines Agency (EMA) is to establish specialised units dedicated to addressing the shortage of medicines and to anticipate potential events that could disrupt public health. 

In a bid to enhance crisis preparedness and ensure timely access to medicines, the Parliament and the Council sealed an agreement yesterday to strengthen EMA, as part of the European Health Union that was proposed by the Commission last November. 

“EU-level preparation and coordination are two essential ingredients to fight future health crises. Thanks to this deal we are adding an essential new building block to upgrade the EU’s health architecture”, Janez Poklukar, Slovenia’s Minister for Health, said, speaking on behalf of the Council.

Medicine shortages

The COVID-19 pandemic exacerbated the growing problem of medical equipment and medicine shortages. During the peak of the pandemic, many national health systems were left struggling to cope with the sudden influx of patients.

In March 2020, the European University Hospital Alliance warned that rising demand in intensive care units for certain anaesthetics, antibiotics, muscle relaxants and medicines that were utilised in the all-out effort to treat COVID-19 meant that inventory stocks were liable to run out.

Decreased production, logistical problems, export bans and stockpiling because of COVID-19 further complicated the risk of bottlenecks.

According to the Parliament, more than 50% of medicines to treat cancer, infections and disorders of the nervous system — epilepsy, Parkinson’s e.g.— accounted for more than half of those in short supply.

“[The new agreement] will allow the EU’s medicines agency to make sure we have the medicines needed to deal with public health emergencies”, Poklukar declared.

“The COVID-19 pandemic has made the general public aware of the vulnerability of supply chains for medicines and medical equipment, a structural issue pharmacies have been faced with for over a decade already”, noted the President of the Pharmaceutical Group of the European Union (PGEU), Alain Delgutte.

EMA’s new role

With the new deal, the EU medicines watchdog’s capacity to manage the regular availability of medicinal products and medical devices will be strengthened. In particular, EMA will set up two “shortages steering groups”, one for medicines, the other for medical devices. 

These steering groups will meet regularly and more frequently whenever the situation requires, in order to prepare appropriately for or during a public health emergency, the Parliament stated. The EMA’s new clusters will also welcome relevant expert advice.

The Parliament insisted that, in order to safeguard transparency, summaries of their proceedings and recommendations must be made publicly available.

“With this agreement, Parliament makes both the Agency and all actors in the supply chain more transparent, involving them more in the process and fostering synergies between EU agencies”, MEP Nicolas Gonzalez Casares (S&D), observed. 

“EMA will now have a big role to play in keeping medicines flowing and making sure they reach the people who need them”, the Director General of the European Consumer Organisation (BEUC), Monique Goyens, added.

Monitoring Platform

MEPs have also proposed setting up the European Shortages Monitoring Platform to collect and assess information on shortages, supply and demand of drugs. The Platform will act as a starting point for “an early warning system” for drug shortages.

The agency will maintain a public webpage displaying the level of shortages of critical medicines and medical devices.

The digitalisation of the sector has been described as key to an efficient regulation of EU pharmaceuticals and specifically to address the issue of medicines shortages in the EU.

Barriers

The head of the European association representing generics and biosimilars has complained that current EU regulatory systems are “too overwhelmed” simply by paper and packaging.

“Sometimes we have a lot of barriers within the EU itself. This could be different packaging and leaflet requirements or languages,” Adrian van den Hoven, Director General of Medicines for Europe, noted. 

“When you have a shortage situation, you want to move excess stock from Country A to Country B in Europe, it’s actually quite difficult to do”, he added.

On the production side, the EU is highly dependent on third countries. For example, 40% of finished medicines on the European market come from China or India. 

The two countries also produce 80% of APIs, the active pharmaceutical ingredients used to manufacture medicines.

Van den Hoven cited the “big discussion” ongoing in Europe on how to reduce the risk of supply disruptions and shortages in welcoming the new arrangement. “Consumers and patients will be better off after today’s agreement which should lead to faster and better coordination in the EU to solve medicine shortages”.

Tags: Biweekly MartaBrussels LatestEurope-FeatureMain-SliderOpinion section
Facebook Twitter Youtube LinkedIn

About Us

Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

Category

  • Ambassador’s Corner
  • Belgium News
  • Brussels
  • Commission
  • Council
  • Culture and Society
  • Diplomacy
  • Economy
  • EU Institutions
  • Europe
  • Europe With Transparency
  • Features
  • In Depth
  • Member States
  • Middle East Eye
  • Opinion
  • Our pick
  • Parliament
  • Place de la Bourse
  • Southeast Europe
  • Sustainable Perspective
  • The American Angle
  • The Macro-Economist
  • Uncategorised
  • US Elections
  • World

More info

  • About Us
  • Advertising
  • Cookies Policy
  • Contact Us
  • FAQ
  • Jobs

Brussels Morning Newspaper - All Rights Reserved © 2020

No Result
View All Result
  • Home
  • About Us
  • EU Institutions
    • Parliament
    • Commission
    • Council
  • Europe
  • World
  • Member States
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Sustainable Perspective
    • The American Angle
    • Southeast Europe
  • Print Magazine

Brussels Morning Newspaper - All Rights Reserved © 2020

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT